These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20381446)

  • 1. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype.
    Karpinski P; Myszka A; Ramsey D; Misiak B; Gil J; Laczmanska I; Grzebieniak Z; Sebzda T; Smigiel R; Stembalska A; Sasiadek MM
    Cancer Epidemiol; 2010 Jun; 34(3):338-44. PubMed ID: 20381446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study.
    Van Guelpen B; Dahlin AM; Hultdin J; Eklöf V; Johansson I; Henriksson ML; Cullman I; Hallmans G; Palmqvist R
    Cancer Causes Control; 2010 Apr; 21(4):557-66. PubMed ID: 20012180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
    Li SY; Rong M; Iacopetta B
    Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.
    Matsuo K; Ito H; Wakai K; Hirose K; Saito T; Suzuki T; Kato T; Hirai T; Kanemitsu Y; Hamajima H; Tajima K
    Carcinogenesis; 2005 Dec; 26(12):2164-71. PubMed ID: 16051637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.
    Curtin K; Slattery ML; Ulrich CM; Bigler J; Levin TR; Wolff RK; Albertsen H; Potter JD; Samowitz WS
    Carcinogenesis; 2007 Aug; 28(8):1672-9. PubMed ID: 17449906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
    Frazier ML; Xi L; Zong J; Viscofsky N; Rashid A; Wu EF; Lynch PM; Amos CI; Issa JP
    Cancer Res; 2003 Aug; 63(16):4805-8. PubMed ID: 12941799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer.
    Iacopetta B; Heyworth J; Girschik J; Grieu F; Clayforth C; Fritschi L
    Int J Cancer; 2009 Jul; 125(1):84-90. PubMed ID: 19326430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
    Teodoridis JM; Hardie C; Brown R
    Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer.
    Koushik A; Kraft P; Fuchs CS; Hankinson SE; Willett WC; Giovannucci EL; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2408-17. PubMed ID: 17164363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer].
    Cai GX; Xu Y; Cai SJ; Shi YQ; Lian P; Peng JJ; Guan ZQ; Du X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):555-60. PubMed ID: 18000779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
    Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylator phenotypes in aging and cancer.
    Toyota M; Issa JP
    Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Watanabe G; Iacopetta B
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5860-5. PubMed ID: 14676107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer.
    Hubner RA; Lubbe S; Chandler I; Houlston RS
    Hum Mol Genet; 2007 May; 16(9):1072-7. PubMed ID: 17350979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylation of DNA damage response genes in advanced ovarian cancer.
    Teodoridis JM; Hall J; Marsh S; Kannall HD; Smyth C; Curto J; Siddiqui N; Gabra H; McLeod HL; Strathdee G; Brown R
    Cancer Res; 2005 Oct; 65(19):8961-7. PubMed ID: 16204069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.
    Kawakami K; Matsunoki A; Kaneko M; Saito K; Watanabe G; Minamoto T
    Cancer Sci; 2011 Jan; 102(1):166-74. PubMed ID: 21087350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation in colorectal adenomas.
    Rashid A; Shen L; Morris JS; Issa JP; Hamilton SR
    Am J Pathol; 2001 Sep; 159(3):1129-35. PubMed ID: 11549606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.